Search

Eyewire News: The Podcast

Eyewire News: The Podcast

06.10.26

Study Examines Semaglutide and Wet AMD Risk

An international study examines the link between a popular weight loss medication and wet AMD risk; Heidelberg receives FDA clearance for a Spectralis software upgrade; and Bausch + Lomb launches its latest over-the-counter dry eye relief product in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

06.24.26

Ocular Updates Plans for Axpaxli NDA for Wet AMD

06.17.26

Tecnis PureSee IOL Fully Launched in the US

06.10.26

Study Examines Semaglutide and Wet AMD Risk

06.03.26

Oculis Announces Phase 3 Results for DME Eye Drops

05.27.26

Outlook Wins Appeal for Wet AMD Drug Candidate Lytenava

05.20.26

Next-Generation FSYX Goggles Approved for Glaucoma

05.13.26

Future of Posterior Therapeutics

05.06.26

Bayer Acquires Perfuse in $2.45 Billion Deal

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D